Ticker Details
Enliven Therapeutics, Inc.
IPO Date:	February 24, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.54B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.62 | 3.19%
Avg Daily Range (30 D):	$0.79 | 3.00%
Avg Daily Range (90 D):	$0.76 | 3.54%

Institutional Daily Volume
Avg Daily Volume:	.28M
Avg Daily Volume (30 D):	.91M
Avg Daily Volume (90 D):	.76M

Trade Size
Avg Trade Size (Sh.):	69
Avg Trade Size (Sh.) (30 D):	67
Avg Trade Size (Sh.) (90 D):	71

Institutional Trades
Total Institutional Trades:	847
Avg Institutional Trade:	$1.5M
Avg Institutional Trade (30 D):	$1.8M
Avg Institutional Trade (90 D):	$1.49M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.48M
Avg Closing Trade (30 D):	$2.26M
Avg Closing Trade (90 D):	$1.56M
Avg Closing Volume:	69.3K

News

Aug 13, 2025 @ 10:15 PM Enliven Posts Loss Beat and Cash Surge Source: Jesterai

Oct 14, 2024 @ 7:05 PM Enliven Therapeutics, Inc. Is a Great Choice for '... Source: Zacks

Sep 28, 2024 @ 1:35 PM Enliven Therapeutics Announces Positive Data Updat... Source: N/A

Jul 16, 2024 @ 10:44 PM Enliven Therapeutics COO sells over $1.25m in comp... Source: Investing.Com

May 29, 2024 @ 8:05 PM Enliven Therapeutics to Present at Two Upcoming In... Source: Enliven Therapeutics, Inc.

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.32		$-.57
Diluted EPS	$-.32		$-.57
Revenue	$M		$M
Gross Profit
Net Income / Loss	$-20.15M	$-25.34M	$-28.54M
Operating Income / Loss	$-25.1M		$-31.69M
Cost of Revenue
Net Cash Flow			$-22.47M
PE Ratio